The novel coronavirus has infected more than 4 million people and killed more than 280,000 worldwide. In the United States, testing for the virus is a key piece of public health officials’ approach to containing the COVID-19 pandemic. But what is the state of testing, and is it sufficient, as the states decide to reopen businesses? What is the difference between testing for the virus and testing for antibodies? And how does the U.S. response differ from that of other nations? Join us on Wednesday, May 13 at 2:00pm EST as Dr. Joshua Sharfstein, vice dean at Johns Hopkins Bloomberg School of Public Health and former FDA deputy commissioner, and PBS NewsHour’s William Brangham, answer your questions on COVID-19 testing.
Data credit: http://USAfacts.org
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Snapchat: @pbsnews
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
